Short answer
PALVELLA THERAPEUTICS, INC. (PVLA) filed an 8-K current report with the SEC on May 13, 2026 reporting Item 8.01 (Other Events). Nasdaq Capital Market-to-Global Market transfer effective May 13, 2026.
PALVELLA THERAPEUTICS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Nasdaq Capital Market-to-Global Market transfer effective May 13, 2026
- Existing PVLA ticker unchanged, preserving trading continuity for shareholders
- Higher Nasdaq tier may improve institutional visibility and perceived listing quality
- Transfer reflects Nasdaq qualification approval, not a change in company operations or ownership
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other PALVELLA THERAPEUTICS, INC. 8-K filings
Get the next PVLA 8-K as it lands
Follow PVLA for push alerts, or ask the research agent what this filing means.